EN DE

Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) Fair Value & Analysis

Basic Materials · IN · Market cap ₹8.3B

SR Sree Rayalaseema Hi-Strength Hypo Limited SRHHYPOLTD · NSE
Price₹496.05
Fair Value₹485.06
Upside-2.2%
Quality69/100
Watch Sree Rayalaseema Hi-Strength Hypo Limited for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Solidly profitable · 13.5% net margin
Low debt · generates free cash flow
0.62% dividend yield
Ranks above peers (10/14)
Moderate moat 48/100
Evidence: High Range ₹380.62 – ₹634.54 Share as image

Fair value as of: Aug 13, 2026

From 26 valuation models · updated 4 days ago

Fair value updated Aug 13, 2026, revised from ₹815.70 to ₹485.06 (−40.5%) since Aug 8, 2026. Share price +1.0% over the past month.

A solid business, currently priced close to our fair value.

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Our model range runs from ₹380.62 (bear) to ₹634.54 (bull), base ₹485.06. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 69/100 (solid quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

₹894.06 ₹268.60 Fair Value ₹485.06 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range ₹268.60 – ₹894.06 · fair‑value band ₹380.62 – ₹634.54 · the ₹496.05 price screens above the ₹485.06 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) currently trades at ₹496.05, while our model-based Fair Value estimate is ₹485.06, implying the stock looks roughly 2.2% fairly valued today. The Quality Score stands at 69/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Sree Rayalaseema Hi-Strength Hypo Limited generated revenue of ₹6.7B at a net margin of 13.5%. Revenue grew 1.7% year over year. It earns a return on equity of 9.4%. The balance sheet holds a net cash position of ₹4.3B. Fundamentals as of Aug 13, 2026

Our scenario range runs from ₹380.62 (bear case) to ₹634.54 (bull case); at ₹496.05, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 30% below its 52-week high and 30% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -60% fair-value upside, at -2%, SRHHYPOLTD screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF ₹697.82 ₹898.61 ₹1,174 80
Residual Income ₹477.78 ₹521.27 ₹715.52 76
Rev-Margin DCF ₹661.12 ₹896.61 ₹1,167 74
All 26 models by family
DCF Models
FCF DCF ₹691.71 ₹919.91 ₹1,254 38
Owner Earnings ₹827.53 ₹1,127 ₹1,565 31
5Y Revenue Exit ₹661.12 ₹895.27 ₹1,192 39
5Y EBITDA Exit ₹632.45 ₹841.68 ₹1,083 41
5Y P/E Exit ₹792.90 ₹1,142 ₹1,507 38
10Y Revenue Exit ₹656.37 ₹869.56 ₹1,153 36
10Y EBITDA Exit ₹650.38 ₹833.20 ₹1,071 37
10Y P/E Exit ₹750.37 ₹1,037 ₹1,387 35
Earnings-Based
Graham-Dodd ₹357.12 ₹1,109 ₹1,475 54
Lynch FV ₹240.79 ₹343.99 ₹447.19 50
PEG = 1.0 ₹240.79 ₹343.99 ₹447.19 46
EPV ₹523.30 ₹565.59 ₹602.09 59
Dividend Discount
Gordon GGM ₹26.35 ₹52.50 ₹79.50 70
DDM Multi-Stage ₹26.35 ₹42.77 ₹55.42 61
Multiples
P/E Multiple ₹669.60 ₹892.80 ₹1,116 63
P/S Multiple ₹437.13 ₹582.84 ₹728.55 58
P/B Multiple ₹669.60 ₹892.80 ₹1,116 55
EV/EBIT ₹752.32 ₹917.96 ₹1,084 53
EV/EBITDA ₹641.98 ₹770.83 ₹899.69 54
EV/Revenue ₹663.40 ₹838.25 ₹1,013 43
Asset-Based
NCAV (Graham) ₹282.88 ₹379.06 ₹565.75 50
Growth DCF
Growth DCF ₹697.82 ₹898.61 ₹1,174 80
Rev-Margin DCF ₹661.12 ₹896.61 ₹1,167 74
Economic Profit
Residual Income ₹477.78 ₹521.27 ₹715.52 76
ROIC Compounder ₹523.30 ₹565.59 ₹637.59 72
Growth Earnings
Growth-Adj P/E ₹567.02 ₹810.02 ₹1,053 68

Widest divergence: Growth DCF (₹896.61) versus Dividend Discount (₹42.77). Highest evidence: Growth DCF (80).

Notify me when SRHHYPOLTD reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) ₹6.7B
Revenue growth (YoY) +1.7%
Net margin 13.5%
Return on equity 9.4%
Free cash flow ₹694M FY2026
P/E ratio 9.3
More key figures
Operating margin 7.0%
EPS (TTM) ₹53.27
Dividend yield 0.6%
EPS growth (YoY) -17.4%
Net cash ₹4.3B FY2026

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 69/100

Of which business quality 68 · Market factors (momentum, volatility) 44

Profitability 48
Margins and returns on capital today
Quality Growth 46
Are margins and returns improving?
Cashflow 54
Earnings quality: real cash, not paper profit
Fin. Strength 100
Balance sheet, leverage, solvency risk
Investment 74
Disciplined investing over empire-building
Low Volatility 82
Calm price path (market factor)
Momentum 32
Price trend over the last 3–12 months (market factor)
52W Momentum 23
Distance to the 52-week high (market factor)
Net Issuance 91
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Sree Rayalaseema Hi-Strength Hypo Limited produces and sells industrial chemicals in India. It operates through three segments: Chemical Manufacturing; Power Generation; and Trading in Coal.

Full company description

Sree Rayalaseema Hi-Strength Hypo Limited produces and sells industrial chemicals in India. It operates through three segments: Chemical Manufacturing; Power Generation; and Trading in Coal. The company provides sulphuric, chlorosulphonic, hydrochloric, and monochloro acetic acids; purichlor, chloramine, oleum, sodium dichloroisocyanurate, and hydrogen gas; and aluminum sulphate, stable bleaching powder, sodium hydride, sodium methoxide powder and solution, and water treatment chemicals. It is involved in the generation and distribution of power through thermal, wind, and solar plants; and coal trading business. The company also exports its products. Sree Rayalaseema Hi-Strength Hypo Limited was incorporated in 2005 and is based in Kurnool, India.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Sree Rayalaseema Hi-Strength Hypo Limited reported revenue of ₹6.7B in FY2026 versus ₹12.6B in FY2022, a compound −14.7%/yr. Reported net income was ₹901M in FY2026, compounding −3.2%/yr from FY2022.

Growth Quality 55/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2026)
₹6.7B
Latest YoY
+4.6%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−26.1%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−6.0%
Avg. growth/yr (19Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+9.5%
Revenue −14.7%/yr
FY22 ₹12.6B
FY23 ₹16.5B
FY24 ₹8.6B
FY25 ₹6.4B
FY26 ₹6.7B
Net income −3.2%/yr
FY22 ₹1.0B
FY23 ₹1.5B
FY24 ₹790M
FY25 ₹875M
FY26 ₹901M
Character of growth · EPS growth decomposed (2015-2026) +15.7 % p.a.
Revenue per share +6.5 pp

of which total revenue +7.6 pp · buybacks/dilution −1.1 pp

EBIT margin +6.5 pp
Tax rate −1.8 pp
Residual (interest, one-offs) +4.5 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch SRHHYPOLTD: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Sree Rayalaseema Hi-Strength Hypo Limited Fair Value". https://www.fairvalue-calculator.com/stock/SRHHYPOLTD

Peer Group

Chemicals · 332 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 69 · Top 25%
Fair Value upside −2% · Above median
Return on equity (TTM) 9% · Above median
Return on assets 5% · Above median
Net margin (TTM) 14% · Top 25%
Operating margin (TTM) 7% · Below median
Revenue growth 2% · Below median
Dividend yield (TTM) 0.6% · Bottom 25%

Valuation Multiples vs Chemicals median · lower = cheaper

P/E (TTM) 9.3× · Cheaper than 75% of peers
P/B 0.86× · Cheaper than median
P/S (TTM) 1.25× · Pricier than median
P/FCF 0.1× · Cheaper than 75% of peers
EV/EBITDA 4.5× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 30 · sector 0
FUTURE 9 · sector 20
PAST 38 · sector 20
HEALTH 100 · sector 94
DIVIDEND 12 · sector 33

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
BASF SE BASN 1,034 MXN 467.04 MXN -55%
PT Barito Pacific Tbk, BRPT 1,950 IDR 1,608 IDR -18%
LG Chem, Ltd 051910 275,500 KRW 587,755 KRW +113%
SRF Limited 503806 ₹2,609 ₹749.17 -71%
542812 542812 ₹4,709 ₹791.05 -83%
Navin Fluorine International Limited NAVINFLUOR ₹8,357 ₹2,146 -74%
523642 523642 ₹2,484 ₹1,745 -30%
506285 506285 ₹4,048 ₹1,589 -61%
Kansai Nerolac Paints Limited 500165 ₹209.25 ₹80.51 -62%
Deepak Nitrite Limited DEEPAKNTR ₹1,718 ₹679.17 -60%

Compare Sree Rayalaseema Hi-Strength Hypo Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of ₹485.06 versus a price of ₹496.05, about −2% (fairly valued).
What is the fair value of SRHHYPOLTD?
Our model-based fair value for Sree Rayalaseema Hi-Strength Hypo Limited is ₹485.06 (as of Aug 13, 2026), built from audited fundamentals. The current price is ₹496.05.
What is the quality score of SRHHYPOLTD?
Sree Rayalaseema Hi-Strength Hypo Limited has a Quality Score of 69/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
Sree Rayalaseema Hi-Strength Hypo Limited reported trailing-twelve-month revenue of about ₹6.7B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of SRHHYPOLTD?
The net profit margin of Sree Rayalaseema Hi-Strength Hypo Limited is about 13.5%, meaning it keeps roughly 13.5% of revenue as net income. Based on the latest reported figures.
Does Sree Rayalaseema Hi-Strength Hypo Limited pay a dividend?
Sree Rayalaseema Hi-Strength Hypo Limited currently shows a dividend yield of about 0.62% relative to its recent price (as of Aug 13, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Sree Rayalaseema Hi-Strength Hypo Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.